ATHEROSCLEROSIS
Clinical trials for ATHEROSCLEROSIS explained in plain language.
Never miss a new study
Get alerted when new ATHEROSCLEROSIS trials appear
Sign up with your email to follow new studies for ATHEROSCLEROSIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug aims to calm 'Fire' in hardened arteries
Disease control Not yet recruitingThis study is testing whether a new drug called selnoflast can reduce inflammation in the arteries of people with atherosclerosis (hardened arteries) who are at high risk for heart attacks or strokes. About 162 participants who are already on standard heart medications will recei…
Matched conditions: ATHEROSCLEROSIS
Phase: PHASE2 • Sponsor: Genentech, Inc. • Aim: Disease control
Last updated Mar 30, 2026 14:31 UTC
-
AI heart scan aims to spot hidden inflammation, guide treatment
Diagnosis Not yet recruitingThis study is testing whether a new AI software tool, called CaRi-Heart®, can help doctors make better decisions for patients with suspected heart disease. The software analyzes standard heart CT scans to measure inflammation in the arteries, which may help identify patients at h…
Matched conditions: ATHEROSCLEROSIS
Phase: NA • Sponsor: Corazon Medical PC • Aim: Diagnosis
Last updated Apr 03, 2026 14:43 UTC
-
Silent threat: ultrasound scans aim to spot hidden artery damage
Knowledge-focused Not yet recruitingThis study aims to find out how common early artery hardening is in people who have both type 2 diabetes and chronic kidney disease. Researchers will use a safe, painless neck ultrasound to look for these early changes in 96 participants. The goal is to help doctors understand th…
Matched conditions: ATHEROSCLEROSIS
Sponsor: Abdallah Ali Mohammed • Aim: Knowledge-focused
Last updated Apr 03, 2026 14:41 UTC